Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2018-07-23 2018-07-23
Drug Identification Number 01918354 01918354
Brand name COUMADIN TAB 5MG COUMADIN TAB 5MG
Common or Proper name Warfarin Warfarin
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients WARFARIN SODIUM WARFARIN SODIUM
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 BTL x 100 1 BTL x 100
ATC code B01AA B01AA
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-07-31 2018-07-31
Actual start date
Estimated end date 2018-08-03 2018-08-03
Actual end date 2018-07-23 2018-07-23
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments Stock available as of July 23rd, 2018 Stock available as of July 23rd, 2018
Health Canada comments